透皮冠状动脉干预后住院和30天死亡率的当代风险模型
1Department of Medicine, University of Washington, Seattle, WA, USA.
Current cardiology reports
|April 9, 2024
概括
当代风险模型有效预测穿皮冠心干预 (PCI) 后的死亡率. 这些工具有助于知情同意和风险评估,CathPCI模型被推用于美国住院死亡率预测.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 健康 结果 研究 研究 结果
背景情况:
- 穿皮冠状动脉干预 (PCI) 后死亡风险模型未得到充分利用.
- 这些模型可以增强医院和运营商的知情同意,风险减轻和结果调整.
研究的目的:
- 分析当代风险模型,预测PCI后的住院和30天死亡率.
- 确定接受PCI的患者死亡率的关键预测因素.
主要方法:
- 对八种PCI死亡率的当代风险模型进行系统审查.
- 分析一致识别的死亡率的独立风险因素.
主要成果:
- 年龄,性别,血液动力学状况,急性冠状动脉综合征类型,心力衰竭和病是重要的预测因素.
- 模型表明,在预 катетеризация和综合风险评估方面,存在强烈的歧视 (C-统计数据为0.85-0.95).
- 在美国,CathPCI模型被推作为医院死亡率预测的默认模型.
结论:
- 有几个有效的风险预测模型存在于PCI相关死亡率.
- 模型选择应与特定的临床用例和患者群体保持一致.
- 未来的努力应优先考虑将风险预测工具纳入常规临床实践.
更多相关视频
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.4K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.4K
相关概念视频
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
